Back to search

Finland· FI-REL-REL14970

Porcilis Porcoli Diluvac Forte

A escherichia rokote product containing escherichia coli, lt toxoid + escherichia coli, f4a antigen + escherichia coli, f4ac antigen + escherichia coli, f5 antigen + 1 more, registered in Finland by Intervet International B.V.. The same ATC class is registered in 2 of our 19 countries.

ATC QI09AB02

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedPorcilis Porcoli Diluvac ForteATCQI09AB02REGISTER NO.FI-REL-REL14970PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Escherichia coli, lt toxoid + escherichia coli, f4a antigen + escherichia coli, f4ac antigen + escherichia coli, f5 antigen + 1 more is registered in 2 of 19 countries.

Countries holding a registration under ATC QI09AB02 (escherichia rokote), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 1 of them publish a price we can compare per daily dose

Escherichia coli, lt toxoid + escherichia coli, f4a antigen + escherichia coli, f4ac antigen + escherichia coli, f5 antigen + 1 more · ATC QI09AB02

2 / 19 countries

  • Denmark
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Escherichia coli, LT toxoid + Escherichia coli, F4A antigen + Escherichia coli, F4ac antigen + Escherichia coli, F5 antigen + 1 more
Manufacturer
Intervet International B.V.
Country
Finland (FI)
ATC code
QI09AB02
ATC class
Escherichia rokote
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/11508e56-00b0-4083-98b7-2482d50fda1e
GET /v1/drugs/11508e56-00b0-4083-98b7-2482d50fda1e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "injektioneste, suspensio",
  "route": "Lihakseen",
  "ddd_unit": null,
  "strength": null,
  "atc_label": "Escherichia rokote",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/2/96/001/003-008",
  "fimea_rel_id": "REL14970",
  "authorised_at": "2002-05-22"
}

See everything about escherichia coli, lt toxoid + escherichia coli, f4a antigen + escherichia coli, f4ac antigen + escherichia coli, f5 antigen + 1 more.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.